ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

220
Analysis
Health CareJapan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
Refresh
16 May 2018 09:05

Takeda FVE Reduction Leaves Shares Slightly Undervalued; Shire Acquisition Neutral to Valuation

We’ve slightly lowered our Takeda Pharmaceutical Co Ltd (4502 JP) fair value estimate to JPY 5,100 from JPY 5,400 after incorporating the close of...

Logo
197 Views
Share
15 May 2018 00:29

Takeda FY17 Earnings - First Glance

Takeda Pharmaceutical Co Ltd (4502 JP) reported FY17 results on May 14, 2018 As anticipated, Entyvio (YoY 35.9% to ¥196.6b), Takecab (YoY 61.7% to...

13 May 2018 22:45

The Week That Was in North Asia @Smartkarma: Do Donkis Rohm the North Korean Shires?

Firstly, apologies for the terrible string of puns, but the image just sticks in our head.Kospi rose 0.66% for the week while Topix rose 1.32%,...

Logo
Mio Kato
199 Views
Share
13 May 2018 00:21

Last Week in Event SPACE: Samsung Biologics, Shire, Lotte, Mitula, JSW, Nisshinbo

Last Week in Event SPACE ... In what is probably the secondmost interesting arb in the world, the attractive trade may simply be to go long LIFULL...

Logo
236 Views
Share
12 May 2018 09:53

Japan Sector Weights: 3 Month % Change - Services ▲ Healthcare ▼ as Global Cyclicals Recover

THREE MONTH % CHANGE IN SECTOR WEIGHTS - The presentation here differs from our most recent sector weight insight (Japan Sector Weights) which...

Logo
95 Views
Share
x